ORKA

Oruka Therapeutics, Inc. - Common Stock (ORKA)

About Oruka Therapeutics, Inc. - Common Stock (ORKA)

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Details

Daily high

$10.66

Daily low

$9.99

Price at open

$10.24

52 Week High

$33.00

52 Week Low

$5.48

Market cap

384.9M

Dividend yield

0.00%

Volume

167,125

Avg. volume

396,809

P/E ratio

-1.60

Oruka Therapeutics, Inc. - Common Stock News